"The U.S. Food and Drug Administration announced today that injectable drugs used in total parenteral nutrition (TPN) in critical shortage will be imported into the United States and available to patients this week.
TPN is an intravenous"...
(Generic versions may still be available.)
Anturane Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Anturane (sulfinpyrazone) is an auricosuric agent used to treat gout and gouty arthritis. The brand name of this medication is discontinued, but generic versions may be available. Common side effects include heartburn, nausea, and upset stomach.
The initial dose of Anturane is 200-400 mg daily in two divided doses, with meals or milk, gradually increasing when necessary to full maintenance dosage in one week. Anturane may interact with aspirin and other salicylates, acetaminophen (Tylenol), warfarin, tolbutamide, theophylline, verapamil, and niacin. Tell your doctor all medications and supplements you use. It is unknown if Anturane will harm a fetus. Tell your doctor if you are pregnant before taking Anturane. It is also unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our Anturane (sulfinpyrazone) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Anturane FDA Prescribing Information: Side Effects
The most frequently reported adverse reactions with Anturane (sulfinpyrazone) have been upper gastrointestinal disturbances. In these patients it is advisable to administer the drug with food, milk, or antacids. Despite this precaution, Anturane (sulfinpyrazone) may aggravate or reactivate peptic ulcer.
Blood dyscrasias (anemia, leukopenia, agranulocytosis, thrombocytopenia, and aplastic anemia) have rarely been reported. There has also been a published report associating Anturane (sulfinpyrazone) , administered concomitantly with other drugs including colchicine, with leukemia following long term treatment of patients with gout. However, the circumstances involved in the two cases reported are such that a cause-and-effect relationship to Anturane (sulfinpyrazone) has not been clearly established.
Read the entire FDA prescribing information for Anturane (Sulfinpyrazone)
Additional Anturane Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.